Concepedia

Mark A. O’Reilly

MA

3

Publications

248

Citations

3

H-Index

2002

Active since

Affiliations

Pfizer (United Kingdom)(Current)

Mark A. O’Reilly is an author at Pfizer (United Kingdom) specializing in signal transduction, medicine, and pharmacology.

Top concepts

MedicinePharmacologySignal TransductionCell BiologyCell SignalingMolecular PhysiologyAllergyImmunologyEngineeringBiochemistry

Publications per year

2002–2011

3

Publications

3

IDENTIFICATION OF A HISTAMINE H<sub>4</sub>RECEPTOR ON HUMAN EOSINOPHILS—ROLE IN EOSINOPHIL CHEMOTAXIS

Mark A. O’Reilly, Robbin Alpert, Stephen Jenkinson et al. · Journal of Receptors and Signal Transduction · 2002 · 193 citations

Inflammation, Cytokine, Molecular Physiology +13

Fragment based discovery of a novel and selective PI3 kinase inhibitor

Samantha Jane Hughes, David S. Millan, Iain Kilty et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 40 citations · Full text

Medicinal Chemistry, Drug Target, Signal Transduction +11

Activation of an α2A-adrenoceptor–Gαo1 fusion protein dynamically regulates the palmitoylation status of the G protein but not of the receptor

Elaine Barclay, Mark A. O’Reilly, Graeme Milligan · Biochemical Journal · 2004 · 15 citations · Full text

Chemical Biology, Cellular Physiology, Molecular Pharmacology +19

Rows per page

1–3 of 3